Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional Results available

Clofarabine and Low Dose Total Body Irradiation as a Preparative Regimen for Stem Cell Transplant in Leukemia.

ClinicalTrials.gov ID: NCT01041508

Public ClinicalTrials.gov record NCT01041508. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 12, 2026, 2:02 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase I Feasibility Study of Clofarabine and Low Dose Total Body Irradiation (TBI) as a Non-myeloablative Preparative Regimen for Stem Cell Transplantation (SCT) for Hematologic Malignancies

Study identification

NCT ID
NCT01041508
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Therapeutic Advances in Childhood Leukemia Consortium
Other
Enrollment
18 participants

Conditions and interventions

Interventions

  • Clofarabine Drug
  • Cyclosporine Drug
  • Mycophenolate Mofetil Drug
  • Stem Cell Transplantation Other
  • Total Body Irradiation Radiation

Drug · Other · Radiation

Eligibility (public fields only)

Age range
1 Year to 21 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 28, 2010
Primary completion
Jul 31, 2014
Completion
Jul 31, 2014
Last update posted
Jan 31, 2024

2010 – 2014

United States locations

U.S. sites
6
U.S. states
6
U.S. cities
6
Facility City State ZIP Site status
Childrens Hospital Los Angeles Los Angeles California 90027
Nationwide Childrens Hospital Columbus Ohio 43205
Oregon Health and Science University Portland Oregon 97239
Vanderbilt Children's Hospital Nashville Tennessee 37232
Primary Children's Hospital Salt Lake City Utah 84113
Seattle Children's Hospital Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01041508, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 31, 2024 · Synced May 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01041508 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →